News articles about CME Group (NASDAQ:CME) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. CME Group earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned news coverage about the financial services provider an impact score of 46.6938649266396 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

Here are some of the media stories that may have impacted Accern Sentiment’s rankings:

CME Group (NASDAQ:CME) traded down $0.53 on Thursday, hitting $139.67. The stock had a trading volume of 1,017,200 shares, compared to its average volume of 1,362,266. The company has a market capitalization of $47,680.00, a PE ratio of 29.33, a PEG ratio of 2.88 and a beta of 0.71. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group has a 1-year low of $111.19 and a 1-year high of $141.44.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. CME Group’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $1.05 earnings per share. analysts anticipate that CME Group will post 4.78 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be paid a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 1.89%. The ex-dividend date of this dividend is Thursday, December 7th. CME Group’s dividend payout ratio is 59.86%.

CME has been the topic of several recent analyst reports. Wells Fargo & Company lifted their price target on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. Royal Bank Of Canada lifted their price target on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Barclays PLC initiated coverage on CME Group in a research report on Friday, September 8th. They issued an “overweight” rating and a $139.00 price target on the stock. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research report on Wednesday, September 13th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $133.00 price target on shares of CME Group in a research report on Thursday, September 21st. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $141.75.

ILLEGAL ACTIVITY NOTICE: This piece was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. and international copyright & trademark law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/11/16/cme-group-cme-earns-daily-media-sentiment-rating-of-0-12.html.

In related news, insider Hilda Harris Piell sold 714 shares of the business’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $129.00, for a total value of $92,106.00. Following the sale, the insider now owns 28,844 shares of the company’s stock, valued at approximately $3,720,876. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction on Monday, August 28th. The shares were sold at an average price of $126.65, for a total value of $107,652.50. Following the completion of the sale, the director now directly owns 13,799 shares in the company, valued at approximately $1,747,643.35. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,339 shares of company stock worth $1,548,086. 0.57% of the stock is owned by insiders.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.